Real-world experience with 11C-methionine PET in the management of acromegaly

CONCLUSION: In patients with persistent/recurrent acromegaly or occult tumours, Met-PET can facilitate further targeted intervention (surgery/radiosurgery). This led to complete remission in most cases (24/33) or significant improvement with comparatively low risk of complications. Met-PET should therefore be considered in all patients who are potential candidates for further surgical intervention, but present no clear target on MRI.PMID:38482632 | DOI:10.1093/ejendo/lvae028

Source: European Journal of Endocrinology - March 14, 2024 Category: Endocrinology Authors: Linus Haberbosch James MacFarlane Olympia Koulouri Daniel Gillett Andrew S Powlson Sue Oddy David J Halsall Kevin A Huynh Jonathan Jones Heok K Cheow Joachim Spranger Knut Mai Christian Strasburger Richard J Mannion Mark Gurnell Source Type: research